Archive for May 2021
GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Gavin Cloherty
WELCOME TO FEATURING DR. GAVIN CLOHERTY – MAY 12, 2021 – “ABBOTT PANDEMIC DEFENSE COALITION – LEGACY AND FUTURE OF ABBOTT INFECTIOUS DISEASE RESEARCH.” Dr. Gavin Cloherty Head of Infectious Disease Research at Abbott, USA Research Fellow in Abbott’s Volwiler Society GVN Corporate Center Director Bio sketch Gavin Cloherty received his bachelors and doctoral degrees…
Read MoreGVN Center and Member Spotlight – Rohit Talwani
Members > Spotlights > Rohit Talwani GVN Center and Member Spotlight Rohit Talwani Associate Professor of Medicine, Institute of Human Virology at the University of Maryland School of Medicine, GVN Center of Excellence Chief, Section of Infectious Diseases, VA Maryland Healthcare System Service Chief for General Infectious Diseases Consult Team at UMMC, USA What are…
Read MoreArchived News Articles
WELCOME TO THE ARCHIVED NEWS Archived News Articles 2023 June 2023 New COVID jabs are coming — who should get them?Nature, June 29, 2023 3 Years Into Long COVID: Where Do We Go From Here?Medscape Infectious Diseases, June 29, 2023 Covid inquiry: ‘No plan’ could have helped Scotland cope’The Herald, June 28, 2023 Long COVID:…
Read MoreVaccine Priorities: Children or Underserved Populations?
Vaccine Priorities: Children or Underserved Populations? May 24, 2021 In the setting of still somewhat limited vaccine supplies and deliveries, a current question is what the most effective priority is among those who are still not vaccinated. What will have the most effective dampening effect on the pandemic? There are several considerations. To what extent…
Read MoreGlobal Virus Network Analysis Suggests Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus
Innate Immunity Created by Live Attenuated Vaccines Like Measles and Polio May Provide Some Protection Against Future Pandemics – Idea Needs To Be Tested, Scientists Say BALTIMORE, MD, May 18, 2021: Members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in…
Read MoreGVN Center and Member Spotlight – Juan Pablo Hernández-Ortiz
GVN Center and Member Spotlight Juan Pablo Hernández-Ortiz, Ph.D. Professor of Materials and Nanotechnology, Universidad Nacional de Colombia, MedellĂn Director, Colombia/Wisconsin One-Health Consortium Honorary Associate at the Pritzker School of Molecular Engineering at the University of Chicago, and The Biotechnology Center at the University of Wisconsin-Madison GVN Member What are you and your institution currently…
Read MoreGVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Penny Moore
WELCOME TO FEATURING DR. PENNY MOORE – APRIL 19, 2021 – “IMMUNITY TO SARS-COV-2 502Y.V2 – IMPLICATIONS FOR VACCINES” Dr. Penny Moore NRF/DST South African Research Chair of Virus-Host Dynamics Reader/Associate Professor, University of the Witwatersrand / National Institute for Communicable Diseases (NICD), South Africa GVN Center Director Bio sketch Prof. Penny Moore is the South African Research…
Read MoreGVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Scott Weaver
WELCOME TO FEATURING DR. SCOTT WEAVER – MARCH 25, 2021 – “VARIANTS OF SARS-COV-2: STUDIES OF TRANSMISSION EFFICIENCY AND SUSCEPTIBILITY TO VACCINE-INDUCED IMMUNITY” Dr. Scott Weaver Chair, Department of Microbiology & Immunology Director, Institute for Human Infections & Immunity Scientific Director, Galveston National Laboratory Professor, Microbiology & Immunology and Pathology GVN Center Director, UTMB Bio sketch…
Read MoreGVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Ralph Baric
WELCOME TO FEATURING DR. RALPH BARIC – FEBRUARY 25, 2021 – “NEW INSIGHTS INTO COVID-19 REPLICATION AND PATHOGENESIS” Dr. Ralph Baric Professor, Department of Epidemiology Professor, Department of Microbiology and Immunology Member, Lineberger Comprehensive Cancer Center The University of North Carolina, United States Bio sketch Dr. Baric is a Distinguished Professor in the Department of…
Read MoreDelta (B.1.617.2)
Background This variant has been named as the Delta variant by the WHO. The Delta variant was first detected in India in December 2020 and became the most commonly reported variant in the country from mid-April 2021. The variant could be more than twice as transmissible as the original strain of SARS-CoV-2. The variant was…
Read More